The Association of the CYP19 and CYP17 Polymorphic Markers with Sporadic Breast Cancer
Authors:
- 1 November 2003
- journal article
- Published by Springer Nature in Molecular Biology
- Vol. 37 (6) , 830-835
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Distinct prevalence of the CYP19 Δ3(TTTA)7 allele in premenopausal versus postmenopausal breast cancer patients, but not in control individualsEuropean Journal of Cancer, 2002
- Polymorphic variation in CYP19 and the risk of breast cancerCarcinogenesis, 2001
- Breast cancer risk associated with polymorphism inCYP19 in Japanese womenInternational Journal of Cancer, 2000
- A tetranucleotide repeat polymorphism inCYP19 and breast cancer riskInternational Journal of Cancer, 2000
- Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer riskCarcinogenesis, 2000
- Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer riskBritish Journal of Cancer, 1999
- Mechanisms by which Thiazolidinediones Enhance Insulin ActionTrends in Endocrinology & Metabolism, 1999
- No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancerBritish Journal of Cancer, 1998
- The genetics of breast and ovarian cancerBritish Journal of Cancer, 1995
- Utilization of Oxygen and Reduced Nicotinamide Adenine Dinucleotide Phosphate by Human Placental Microsomes during Aromatization of AndrostenedioneJournal of Biological Chemistry, 1974